News

Researchers derive novel insights through the combination of PathAI's proprietary tumor microenvironment features with ConcertAI's multi-modal clinical data BOSTON, April 25, 2023 /PRNewswire ...
PathAI has launched the PathAssist Derm AI tool, which is designed for orienting, detecting, and measuring skin lesions. This new offering, now available on the AISight image management system ...
Agilent Technologies A joined forces with PathAI in a bid to introduce an end-to-end solution for AI-powered assay development. Both Agilent and PathAI, which offers AI-powered research tools and ...
PathAI Biopharma chief business officer and president Matt Grow said: “We are thrilled to partner with Clario to provide a cutting-edge solution for IBD [inflammatory bowel disease] clinical trials.
Collaboration includes use of PathAI’s AISight®¹ digital pathology image management system at Northwestern Medicine and joint efforts in research, clinical innovation, and algorithm co ...
Andrew Beck, cofounder and CEO of PathAI, is #31 on The Boston Globe's 2024 Tech Power Players list.
PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, today announced that Nick Anderson, Ph.D., has joined as Vice ...
As part of the transaction, Quest bought out PathAI’s diagnostics lab in Memphis and rebranded the facility as AmeriPath. According to Quest, the site will act as an AI, digital R&D and ...
PathAI will share five new posters, all developed in collaboration with biopharmaceutical partners, that highlight their new AI-model development to support advances in oncology research across ...